ArticleOphthalmology science

Suppression of Neovascularization by Topical and Subconjunctival Bevacizumab After High-Risk Corneal Transplantation.

Thomas H Dohlman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.